The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
Empagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107038 · Cited by 4,874
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Self-citationTafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Self-citationNonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationMolecular Mechanisms of Amyloidosis
Merlini, G., & Bellotti, V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023144 · Cited by 1,920
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,854
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107454 · Cited by 1,801
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., Planté-Bordeneuve, V., Barroso, F. A., Merlini, G., Obici, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716793 · Cited by 1,452
Self-citationMehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
Primary systemic amyloidosis: clinical and laboratory features in 474 cases.
Kyle, R. A., & Ma, G. (1995) · PubMed · Cited by 1,255
Redefining Palliative Care—A New Consensus-Based Definition
Radbruch, L., De Lima, L., Knaul, F., Wenk, R., Ali, Z., Bhatnaghar, S., Blanchard, C., Bruera, E., Buitrago, R., Burla, C., et al. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.04.027 · Cited by 1,249
Garcia-Pavia, P., Rapezzi, C., Adler, Y., Arad, M., Basso, C., Brucato, A., Burazor, I., Caforio, A. L. P., Damy, T., Eriksson, U., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab072 · Cited by 1,231
Self-citationWild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., de Haro-del Moral, F. J., Cobo-Marcos, M., Robles, C., Bornstein, B., Salas, C., Lara-Pezzi, E., Alonso-Pulpon, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,174
Kumar, S., Dispenzieri, A., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Colby, C., Laumann, K., Zeldenrust, S. R., Leung, N., Dingli, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5724 · Cited by 1,137
Transthyretin Amyloid Cardiomyopathy
Ruberg, F. L., Grogan, M., Hanna, M., Kelly, J. W., & Maurer, M. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.003 · Cited by 1,112
Self-citationCrouser, E. D., Maier, L. A., Wilson, K. C., Bonham, C. A., Morgenthau, A. S., Patterson, K. C., Abston, E., Bernstein, R. C., Blankstein, R., Chen, E. S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202002-0251st · Cited by 1,086
Dispenzieri, A., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Burritt, M. F., Therneau, T. M., Greipp, P. R., Witzig, T. E., Lust, J. A., Rajkumar, S. V., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.029 · Cited by 985
Khush, K. K., Cherikh, W. S., Chambers, D. C., Harhay, M. O., Hayes, D., Hsich, E., Meiser, B., Potena, L., Robinson, A., Rossano, J. W., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.08.004 · Cited by 960
Vrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
Coelho, T., Maia, L. F., Martins da Silva, A., Waddington Cruz, M., Planté-Bordeneuve, V., Lozeron, P., Suhr, O. B., Campistol, J. M., Conceição, I. M., Schmidt, H. H.-J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661eb1 · Cited by 816
A new staging system for cardiac transthyretin amyloidosis
Gillmore, J. D., Damy, T., Fontana, M., Hutchinson, M., Lachmann, H. J., Martinez-Naharro, A., Quarta, C. C., Rezk, T., Whelan, C. J., Gonzalez-Lopez, E., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx589 · Cited by 776
Grogan, M., Scott, C. G., Kyle, R. A., Zeldenrust, S. R., Gertz, M. A., Lin, G., Klarich, K. W., Miller, W. L., Maleszewski, J. J., & Dispenzieri, A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.033 · Cited by 763
Kittleson, M. M., Maurer, M. S., Ambardekar, A. V., Bullock-Palmer, R. P., Chang, P. P., Eisen, H. J., Nair, A. P., Nativi-Nicolau, J., Ruberg, F. L., & On behalf of the American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology (2020) · Circulation · doi:10.1161/cir.0000000000000792 · Cited by 756
Self-citationCastaño, A., Narotsky, D. L., Hamid, N., Khalique, O. K., Morgenstern, R., DeLuca, A., Rubin, J., Chiuzan, C., Nazif, T., Vahl, T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx350 · Cited by 726
Self-citationRepurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial
Berk, J. L., Suhr, O. B., Obici, L., Sekijima, Y., Zeldenrust, S. R., Yamashita, T., Heneghan, M. A., Gorevic, P. D., Litchy, W. J., Wiesman, J. F., et al. (2013) · JAMA · doi:10.1001/jama.2013.283815 · Cited by 708
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Kastritis, E., Palladini, G., Minnema, M. C., Wechalekar, A. D., Jaccard, A., Lee, H. C., Sanchorawala, V., Gibbs, S., Mollee, P., Venner, C. P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028631 · Cited by 702
Self-citationLong-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Larson, D. R., Therneau, T. M., Dispenzieri, A., Kumar, S., Cerhan, J. R., & Rajkumar, S. V. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709974 · Cited by 647
Familial amyloid polyneuropathy
Planté-Bordeneuve, V., & Said, G. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70246-0 · Cited by 645
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
Hicks, K. A., Tcheng, J. E., Bozkurt, B., Chaitman, B. R., Cutlip, D. E., Farb, A., Fonarow, G. C., Jacobs, J. P., Jaff, M. R., Lichtman, J. H., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.018 · Cited by 603
Tanskanen, M., Peuralinna, T., Polvikoski, T., Notkola, I., Sulkava, R., Hardy, J., Singleton, A., Kiuru‐Enari, S., Paetau, A., Tienari, P. J., et al. (2008) · Annals of Medicine · doi:10.1080/07853890701842988 · Cited by 591
Maurer, M. S., Bokhari, S., Damy, T., Dorbala, S., Drachman, B. M., Fontana, M., Grogan, M., Kristen, A. V., Lousada, I., Nativi-Nicolau, J., et al. (2019) · Circulation: Heart Failure · doi:10.1161/circheartfailure.119.006075 · Cited by 568
Self-citationVariant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans
Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., & Buxbaum, J. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360703 · Cited by 554
Systemic immunoglobulin light chain amyloidosis
Merlini, G., Dispenzieri, A., Sanchorawala, V., Schönland, S. O., Palladini, G., Hawkins, P. N., & Gertz, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0034-3 · Cited by 552
Self-citationGenotype and Phenotype of Transthyretin Cardiac Amyloidosis
Maurer, M. S., Hanna, M., Grogan, M., Dispenzieri, A., Witteles, R., Drachman, B., Judge, D. P., Lenihan, D. J., Gottlieb, S. S., Shah, S. J., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.596 · Cited by 538
Self-citationNatural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis
Lane, T., Fontana, M., Martinez-Naharro, A., Quarta, C. C., Whelan, C. J., Petrie, A., Rowczenio, D. M., Gilbertson, J. A., Hutt, D. F., Rezk, T., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.038169 · Cited by 535
Tabulation of human transthyretin (TTR) variants, 2003
Connors, L. H., Lim, A., Prokaeva, T., Roskens, V. A., & Costello, C. E. (2003) · Amyloid · doi:10.3109/13506120308998998 · Cited by 505
Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., et al. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01760-6 · Cited by 484
Self-citationFrequency and distribution of senile cardiovascular amyloid
Cornwell, G. G., Murdoch, W. L., Kyle, R. A., Westermark, P., & Pitkänen, P. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90443-6 · Cited by 483
Palladini, G., Sachchithanantham, S., Milani, P., Gillmore, J., Foli, A., Lachmann, H., Basset, M., Hawkins, P., Merlini, G., & Wechalekar, A. D. (2015) · Blood · doi:10.1182/blood-2015-01-620302 · Cited by 450
Epidemiology of AL amyloidosis: a real-world study using US claims data
Quock, T. P., Yan, T., Chang, E., Guthrie, S., & Broder, M. S. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018016402 · Cited by 416
Amyloidosis-Associated Kidney Disease
Dember, L. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050460 · Cited by 409
Self-citationBenson, M. D., Buxbaum, J. N., Eisenberg, D. S., Merlini, G., Saraiva, M. J. M., Sekijima, Y., Sipe, J. D., & Westermark, P. (2020) · Amyloid · doi:10.1080/13506129.2020.1835263 · Cited by 398
Comenzo, R. L., Reece, D., Palladini, G., Seldin, D., Sanchorawala, V, Landau, H., Falk, R., Wells, K., Solomon, A., Wechalekar, A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.100 · Cited by 390
Self-citationPrevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis
Nitsche, C., Scully, P. R., Patel, K. P., Kammerlander, A. A., Koschutnik, M., Dona, C., Wollenweber, T., Ahmed, N., Thornton, G. D., Kelion, A. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.006 · Cited by 377
Transthyretin (Prealbumin) in Health and Disease: Nutritional Implications
Ingenbleek, Y., & Young, V (1994) · Annual Review of Nutrition · doi:10.1146/annurev.nu.14.070194.002431 · Cited by 375
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
Pinney, J. H., Whelan, C. J., Petrie, A., Dungu, J., Banypersad, S. M., Sattianayagam, P., Wechalekar, A., Gibbs, S. D. J., Venner, C. P., Wassef, N., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000098 · Cited by 372
Musunuru, K., Hershberger, R. E., Day, S. M., Klinedinst, N. J., Landstrom, A. P., Parikh, V. N., Prakash, S., Semsarian, C., Sturm, A. C., & on behalf of the American Heart Association Council on Genomic and Precision Medicine; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. C. O. C. C. (2020) · Circulation: Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000067 · Cited by 371
Self-citationGastrointestinal Manifestations of Amyloidosis
Ebert, E. C., & Nagar, M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01669.x · Cited by 366
Hutchison, C. A., Harding, S., Hewins, P., Mead, G. P., Townsend, J., Bradwell, A. R., & Cockwell, P. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02290508 · Cited by 364
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice
Witteles, R. M., Bokhari, S., Damy, T., Elliott, P. M., Falk, R. H., Fine, N. M., Gospodinova, M., Obici, L., Rapezzi, C., & Garcia-Pavia, P. (2019) · JACC: Heart Failure · doi:10.1016/j.jchf.2019.04.010 · Cited by 351
England, J. D., Gronseth, G. S., Franklin, G., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000336345.70511.0f · Cited by 324
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins
Dispenzieri, A., Kyle, R. A., Gertz, M. A., Therneau, T. M., Miller, W. L., Chandrasekaran, K., McConnell, J. P., Burritt, M. F., & Jaffe, A. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13396-x · Cited by 317
How to Image Cardiac Amyloidosis
Dorbala, S., Cuddy, S., & Falk, R. H. (2020) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2019.07.015 · Cited by 308
Jhund, P. S., Solomon, S. D., Docherty, K. F., Heerspink, H. J. L., Anand, I. S., Böhm, M., Chopra, V., de Boer, R. A., Desai, A. S., Ge, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050391 · Cited by 307
Feingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000526 · Cited by 306
Cibeira, M. T., Sanchorawala, V., Seldin, D. C., Quillen, K., Berk, J. L., Dember, L. M., Segal, A., Ruberg, F., Meier-Ewert, H., Andrea, N. T., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330738 · Cited by 289
Self-citationFreeman, R., Abuzinadah, A. R., Gibbons, C., Jones, P., Miglis, M. G., & Sinn, D. I. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.079 · Cited by 280
Miller, D. T., Lee, K., Abul-Husn, N. S., Amendola, L. M., Brothers, K., Chung, W. K., Gollob, M. H., Gordon, A. S., Harrison, S. M., Hershberger, R. E., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.04.006 · Cited by 276
Self-citationPomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial
Sanchorawala, V., Shelton, A. C., Lo, S., Varga, C., Sloan, J. M., & Seldin, D. C. (2016) · Blood · doi:10.1182/blood-2016-04-710822 · Cited by 275
Self-citationDorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., et al. (2021) · Circulation: Cardiovascular Imaging · doi:10.1161/hci.0000000000000029 · Cited by 275
Self-citationHershberger, R. E., Givertz, M. M., Ho, C. Y., Judge, D. P., Kantor, P. F., McBride, K. L., Morales, A., Taylor, M. R. G., Vatta, M., & Ware, S. M. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0039-z · Cited by 272
Self-citationThe Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans
Quarta, C. C., Buxbaum, J. N., Shah, A. M., Falk, R. H., Claggett, B., Kitzman, D. W., Mosley, T. H., Butler, K. R., Boerwinkle, E., & Solomon, S. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404852 · Cited by 263
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy
Kazi, D. S., Bellows, B. K., Baron, S. J., Shen, C., Cohen, D. J., Spertus, J. A., Yeh, R. W., Arnold, S. V., Sperry, B. W., Maurer, M. S., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045093 · Cited by 263
Self-citationDiagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors
Davar, J., Connolly, H. M., Caplin, M. E., Pavel, M., Zacks, J., Bhattacharyya, S., Cuthbertson, D. J., Dobson, R., Grozinsky-Glasberg, S., Steeds, R. P., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.12.030 · Cited by 261
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial
Sanchorawala, V., Wright, D. G., Rosenzweig, M., Finn, K. T., Fennessey, S., Zeldis, J. B., Skinner, M., & Seldin, D. C. (2007) · Blood · doi:10.1182/blood-2006-07-030544 · Cited by 260
Self-citationPeripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management
Watson, J. C., & Dyck, P. J. B. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.05.004 · Cited by 258
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis
Hanna, M., Ruberg, F. L., Maurer, M. S., Dispenzieri, A., Dorbala, S., Falk, R. H., Hoffman, J., Jaber, W., Soman, P., Witteles, R. M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.022 · Cited by 255
Self-citationMiller, D. T., Lee, K., Gordon, A. S., Amendola, L. M., Adelman, K., Bale, S. J., Chung, W. K., Gollob, M. H., Harrison, S. M., Herman, G. E., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01171-4 · Cited by 251
Self-citationDigoxin sensitivity in amyloid cardiomyopathy.
Rubinow, A., Skinner, M., & Cohen, A. S. (1981) · Circulation · doi:10.1161/01.cir.63.6.1285 · Cited by 243
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study
Obici, L., Cortese, A., Lozza, A., Lucchetti, J., Gobbi, M., Palladini, G., Perlini, S., Saraiva, M. J., & Merlini, G. (2012) · Amyloid · doi:10.3109/13506129.2012.678508 · Cited by 231
Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
Quarta, C. C., Gonzalez-Lopez, E., Gilbertson, J. A., Botcher, N., Rowczenio, D., Petrie, A., Rezk, T., Youngstein, T., Mahmood, S., Sachchithanantham, S., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx047 · Cited by 227
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction
AbouEzzeddine, O. F., Davies, D. R., Scott, C. G., Fayyaz, A. U., Askew, J. W., McKie, P. M., Noseworthy, P. A., Johnson, G. B., Dunlay, S. M., Borlaug, B. A., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.3070 · Cited by 220
Cyrille, N. B., Goldsmith, J., Alvarez, J., & Maurer, M. S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.026 · Cited by 218
Self-citationDorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., et al. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01761-5 · Cited by 216
Self-citationSUHR, O., DANIELSSON, Å., HOLMGREN, G., & STEEN, L. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01106.x · Cited by 209
Management of Arrhythmias in Cardiac Amyloidosis
Giancaterino, S., Urey, M. A., Darden, D., & Hsu, J. C. (2020) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2020.01.004 · Cited by 209
Nausea: a review of pathophysiology and therapeutics
Singh, P., Yoon, S. S., & Kuo, B. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15618131 · Cited by 204
Distal symmetrical polyneuropathy: Definition for clinical research
England, J. D., Gronseth, G. S., Franklin, G., Miller, R. G., Asbury, A. K., Carter, G. T., Cohen, J. A., Fisher, M. A., Howard, J. F., Kinsella, L. J., et al. (2005) · Muscle & Nerve · doi:10.1002/mus.20233 · Cited by 203
Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis
El-Am, E. A., Dispenzieri, A., Melduni, R. M., Ammash, N. M., White, R. D., Hodge, D. O., Noseworthy, P. A., Lin, G., Pislaru, S. V., Egbe, A. C., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.079 · Cited by 202
Scully, P. R., Patel, K. P., Treibel, T. A., Thornton, G. D., Hughes, R. K., Chadalavada, S., Katsoulis, M., Hartman, N., Fontana, M., Pugliese, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa170 · Cited by 202
Conceição, I., Damy, T., Romero, M., Galán, L., Attarian, S., Luigetti, M., Sadeh, M., Sarafov, S., Tournev, I., & Ueda, M. (2019) · Amyloid · doi:10.1080/13506129.2018.1556156 · Cited by 199
Singer, W. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1294 · Cited by 196
Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis
Geller, H. I., Singh, A., Alexander, K. M., Mirto, T. M., & Falk, R. H. (2017) · JAMA · doi:10.1001/jama.2017.9236 · Cited by 190
Implantable Cardioverter Defibrillators in Patients with Cardiac Amyloidosis
LIN, G., DISPENZIERI, A., KYLE, R., GROGAN, M., & BRADY, P. A. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12123 · Cited by 188
Jha, S. R., Hannu, M. K., Chang, S., Montgomery, E., Harkess, M., Wilhelm, K., Hayward, C. S., Jabbour, A., Spratt, P. M., Newton, P., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000000991 · Cited by 184
Buxbaum, J. N., & Ruberg, F. L. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.200 · Cited by 178
Self-citationLilleness, B., Ruberg, F. L., Mussinelli, R., Doros, G. D., & Sanchorawala, V. (2018) · Blood · doi:10.1182/blood-2018-06-858951 · Cited by 175
Self-citationLong, T. E., Indridason, Ó. S., Pálsson, R., Rögnvaldsson, S., Löve, Þ. J., Þorsteinsdóttir, S., Sverrisdottir, I. S., Viðarsson, B., Onundarson, P. T., Agnarsson, B. A., et al. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00732-3 · Cited by 170
Damrauer, S. M., Chaudhary, K., Cho, J. H., Liang, L. W., Argulian, E., Chan, L., Dobbyn, A. L., Guerraty, M. A., Judy, R., Kay, J., et al. (2019) · JAMA · doi:10.1001/jama.2019.17935 · Cited by 169
Electrophysiologic Abnormalities in AL (Primary) Amyloidosis With Cardiac Involvement
Reisinger, J., Dubrey, S. W., Lavalley, M., Skinner, M., & Falk, R. H. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00267-2 · Cited by 168
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)
Phull, P., Sanchorawala, V., Connors, L. H., Doros, G., Ruberg, F. L., Berk, J. L., & Sarosiek, S. (2018) · Amyloid · doi:10.1080/13506129.2018.1436048 · Cited by 165
Self-citationTransthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis
Westermark, P., Westermark, G. T., Suhr, O. B., & Berg, S. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.895786 · Cited by 164
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study
Ueda, M., Horibata, Y., Shono, M., Misumi, Y., Oshima, T., Su, Y., Tasaki, M., Shinriki, S., Kawahara, S., Jono, H., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.117 · Cited by 164
Reece, D. E., Sanchorawala, V., Hegenbart, U., Merlini, G., Palladini, G. O., Fermand, J., Vescio, R. A., Liu, X., Elsayed, Y. A., Cakana, A., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203398 · Cited by 161
Self-citationQuantification of sweat gland innervation: A clinical–pathologic correlation
Gibbons, C. H., Illigens, B. M. W., Wang, N., & Freeman, R. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e8b8 · Cited by 161
Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis
Kastritis, E., Leleu, X. P., Arnulf, B., Zamagni, E., Cibeira, M. T., Kwok, F., Mollee, P. N., Hájek, R., Moreau, P., Jaccard, A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01285 · Cited by 159
Adams, D., Polydefkis, M., González-Duarte, A., Wixner, J., Kristen, A. V., Schmidt, H. H., Berk, J. L., Losada López, I. A., Dispenzieri, A., Quan, D., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30368-9 · Cited by 158
Self-citationNativi-Nicolau, J. N., Karam, C., Khella, S. L., & Maurer, M. S. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10080-2 · Cited by 146
Self-citationA Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry–Verified Typing
Muchtar, E., Gertz, M. A., Kyle, R. A., Lacy, M. Q., Dingli, D., Leung, N., Buadi, F. K., Hayman, S. R., Kapoor, P., Hwa, Y. L., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.006 · Cited by 142
Immunoglobulin heavy-chain-associated amyloidosis.
Eulitz, M., Weiss, D. T., & Solomon, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6542 · Cited by 140
Cheng, R., Levy, W., Vasbinder, A., Teruya, S., Santos, J. D. L., Leedy, D., & Maurer, M. (2020) · JACC CardioOncology · doi:10.1016/j.jaccao.2020.06.007 · Cited by 137
Self-citationWixner, J., Mundayat, R., Karayal, O. N., Anan, I., Karling, P., Suhr, O. B., & on behalf of the THAOS investigators (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-61 · Cited by 128
A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Sanchorawala, V., Palladini, G. O., Kukreti, V., Zonder, J. A., Cohen, A. D., Seldin, D. C., Dispenzieri, A. A., Jaccard, A., Schönland, S. O., Berg, D. T., et al. (2017) · Blood · doi:10.1182/blood-2017-03-771220 · Cited by 124
Self-citationVenetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Premkumar, V. J., Lentzsch, S., Pan, S. M., Bhutani, D., Richter, J. R., Jagannath, S., Liedtke, M., Jaccard, A., Wechalekar, A. D., Comenzo, R. L., et al. (2021) · Blood Cancer Journal · doi:10.1038/s41408-020-00397-w · Cited by 124
Self-citationBrownrigg, J. R. W., Lorenzini, M., Lumley, M., & Elliot, P. M. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12511 · Cited by 122
Patterns of Neuropathy and Autonomic Failure in Patients With Amyloidosis
Wang, A. K., Fealey, R. D., Gehrking, T. L., & Low, P. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.11.1226 · Cited by 121
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7
Dyck, P. J. B., González‐Duarte, A., Obici, L. P., Polydefkis, M. J., Wiesman, J. F., Antonino, I., Litchy, W. J., & Dyck, P. J. B. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.116424 · Cited by 117
Current Overview on Clinical Management of Chronic Constipation
Włodarczyk, J., Waśniewska, A., Fichna, J., Dziki, A. J., Dziki, Ł. A., & Włodarczyk, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081738 · Cited by 116
Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome
Westin, O. M., Fosbøl, E. L., Maurer, M. S., Leicht, P., Hasbak, P., Mylin, A. K., Rørvig, S. B., Jensen, T. H. L., Johannesen, H. H., & Gustafsson, F. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.06.026 · Cited by 116
Self-citationKidney dysfunction during lenalidomide treatment for AL amyloidosis
Specter, R., Sanchorawala, V., Seldin, D. C., Shelton, A. C., Fennessey, S. A., Finn, K. T., Zeldis, J. B., & Dember, L. M. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq482 · Cited by 115
Self-citationGrupper, A., Park, S. J., Pereira, N. L., Schettle, S. D., Gerber, Y., Topilsky, Y., Edwards, B. S., Daly, R. C., Stulak, J. M., Joyce, L. D., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.03.012 · Cited by 109
Perspectives in treatment of AL amyloidosis
Wechalekar, A. D., Hawkins, P. N., & Gillmore, J. D. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06936.x · Cited by 105
Matsuda, M., Gono, T., Morita, H., Katoh, N., Kodaira, M., & Ikeda, S. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03215.x · Cited by 104
Hamon, D., Algalarrondo, V., Gandjbakhch, E., Extramiana, F., Marijon, É., Elbaz, N., Selhane, D., Dubois‐Randé, J., Teíger, E., Planté‐Bordeneuve, V., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.254 · Cited by 104
Lim, A. Y., Lee, J. H., Jung, K. S., Gwag, H. B., Kim, D. H., Kim, S. J., Lee, G. Y., Kim, J., Kim, H., Lee, S., et al. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.4.496 · Cited by 103
Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era
Kristen, A. V., Kreußer, M. M., Blum, P., Schönland, S. O., Frankenstein, L., Dösch, A. O., Knop, B., Helmschrott, M., Schmack, B., Ruhparwar, A., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.11.015 · Cited by 101
Gertz, M., Adams, D., Ando, Y., Beirão, J., Bokhari, S., Coelho, T., Comenzo, R., Damy, T., Dorbala, S., Drachman, B., et al. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01252-4 · Cited by 101
Self-citationBhuiyan, T., Helmke, S. T., Patel, A. R., Ruberg, F. L., Packman, J., Cheung, K. N., Grogan, D. R., & Maurer, M. S. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.910455 · Cited by 99
Self-citationPeripheral Neuropathy as an Early Marker of AL Amyloidosis
Duston, M. A. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.2.358 · Cited by 92
Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis
Donnellan, E., Wazni, O. M., Kanj, M. H., Elshazly, M. B., Hussein, A. A., Baranowski, B. J., Hanna, M. A., Patel, D. R., Trulock, K. M., Martyn, M., et al. (2019) · EP Europace · doi:10.1093/europace/euz314 · Cited by 90
Mital, S. R., Musunuru, K., Garg, V., Russell, M. W. W., Lanfear, D. E., Gupta, R. M., Hickey, K. T., Ackerman, M. J., Perez, M. V., Roden, D. M., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/hcg.0000000000000031 · Cited by 89
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?
Muchtar, E., Gertz, M. A., Kumar, S. K., Lin, G., Boilson, B. A., Clavell, A. L., Lacy, M. Q., Buadi, F. K., Hayman, S. R., Kapoor, P., et al. (2018) · Amyloid · doi:10.1080/13506129.2018.1449744 · Cited by 89
Siepen, F. A. D., Bauer, R., Aurich, M., Buss, S. J., Steen, H., Altland, K., Kristen, A. V., & Katus, H. A. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s96893 · Cited by 87
Bochtler, T., Hegenbart, U., Kunz, C., Benner, A., Kimmich, C. R., Seckinger, A., Hose, D., Goldschmidt, H., Granzow, M., Dreger, P., et al. (2016) · Blood · doi:10.1182/blood-2015-10-676361 · Cited by 85
Left ventricular device implantation for advanced cardiac amyloidosis
Swiecicki, P. L., Edwards, B. S., Kushwaha, S. S., Dispenzieri, A. A., Park, S. J., & Gertz, M. A. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.01.987 · Cited by 84
Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis
Geller, H. I., Singh, A., Mirto, T. M., Padera, R. F., Mitchell, R. N., Laubach, J. P., & Falk, R. H. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.09.016 · Cited by 84
Two types of amyloidosis presenting in a single patient: a case series
Sidiqi, M. H., McPhail, E. D., Theis, J. D., Dasari, S., Vrana, J. A., Drosou, M. E., Leung, N., Hayman, S. R., Rajkumar, S. V., Warsame, R. M., et al. (2019) · Blood Cancer Journal · doi:10.1038/s41408-019-0193-9 · Cited by 82
Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis
Gilstrap, L. G., Niehaus, E. D., Malhotra, R. K., Ton, V., Watts, J. A., Seldin, D. C., Madsen, J. C., & Semigran, M. J. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.09.004 · Cited by 80
Iida, T., Yamano, H., & Nakase, H. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13996 · Cited by 79
Rapezzi, C., Aimo, A., Serenelli, M., Barison, A., Vergaro, G., Passino, C., Panichella, G., Sinagra, G., Merlo, M., Fontana, M., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.036 · Cited by 78
Self-citationBrannagan, T. H., Wang, A. K., Coelho, T., Waddington‐Cruz, M., Polydefkis, M. J., Dyck, P. J. B., Planté‐Bordeneuve, V., Berk, J. L., Barroso, F. A., Merlini, G., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14285 · Cited by 74
Self-citationSafety and Tolerability of Neurohormonal Antagonism in Cardiac Amyloidosis
Aimo, A., Vergaro, G., Castiglione, V., Rapezzi, C., & Emdin, M. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.015 · Cited by 74
Dispenzieri, A. A., Kastritis, E., Wechalekar, A. D., Schönland, S. O., Kım, K., Sanchorawala, V., Landau, H. J., Kwok, F., Suzuki, K., Comenzo, R. L., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01317-y · Cited by 63
Self-citationPrognostic value of cardiopulmonary exercise testing in cardiac amyloidosis
Nicol, M., Deney, A., Lairez, O., Vergaro, G., Emdin, M., Carecci, A., Inamo, J., Montfort, A., Nevière, R., Damy, T., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2016 · Cited by 57
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
Kastritis, E., Dialoupi, I., Gavriatopoulou, M., Ρούσσου, Μ., Kanellias, N., Fotiou, D., Ntanasis‐Stathopoulos, I., Papadopoulou, E., Ziogas, D. C., Stamatelopoulos, K. S., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000147 · Cited by 56
Siragusa, S. M., Morice, W. G., Gertz, M. A., Kyle, R. A., Greipp, P. R., Lust, J. A., Witzig, T. E., Lacy, M. Q., Zeldenrust, S. R., Rajkumar, S. V., et al. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1028-8 · Cited by 55
Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
Cheng, R. K., Vasbinder, A., Levy, W., Goyal, P., Griffin, J., Leedy, D. J., & Maurer, M. (2021) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.121.022859 · Cited by 53
Self-citationCampbell, C. M., LoRusso, S. J., Dispenzieri, A. A., Kristen, A. V., Maurer, M. S., Rapezzi, C., Lairez, O., Drachman, B. M., García‐Pavía, P., Grogan, M. A., et al. (2022) · Cardiology and Therapy · doi:10.1007/s40119-022-00265-7 · Cited by 52
Self-citationThe prevalence and distribution of the amyloidogenic transthyretin ( TTR ) V122I allele in Africa
Jacobson, D. R., Alexander, A. A., Tagoe, C. E., Garvey, W. T., Williams, S. M., Tishkoff, S., Modiano, D., Sirima, S. B., Kalidi, I., Toure, A., et al. (2016) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.231 · Cited by 51
Parker, M. M., Damrauer, S. M., Tcheandjieu, C., Erbe, D. V., Aldinc, E., Hawkins, P. N., Gillmore, J. D., Hull, L. E., Lynch, J. A., Joseph, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91113-6 · Cited by 51
Hanna, M. A., Damy, T., Grogan, M. A., Stewart, M., Gundapaneni, B. K., Patterson, T. A., Schwartz, J. H., Sultan, M. B., & Maurer, M. S. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.10.066 · Cited by 50
Self-citationDigoxin Use in Cardiac Amyloidosis
Donnelly, J. P., Sperry, B. W., Gabrovsek, A., Ikram, A., Tang, W. H. W., Estep, J. D., & Hanna, M. A. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.07.034 · Cited by 49
Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
Parcha, V., Malla, G., Ivin, M. R., Armstrong, N., Judd, S., Lange, L., Maurer, M., Levitan, E., Goyal, P., Arora, G., et al. (2022) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2022.2896 · Cited by 46
Self-citationJessup, M. L., Drazner, M. H., Book, W., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.001 · Cited by 45
Kleefeld, F., Scherret, E., Knebel, F., Messroghli, D., Heidecker, B., Wetz, C., Schatka, I., Barzen, G., Tschöpe, C., Amthauer, H., et al. (2022) · Amyloid · doi:10.1080/13506129.2021.2014448 · Cited by 41
Mechanical circulatory support for cardiac amyloidosis
Kittleson, M. M., Cole, R. M., Patel, J. K., Ramzy, D., Passano, E., Chang, D., Geft, D. R., Czer, L. S. C., Vescio, R. A., Chung, J. S., et al. (2019) · Clinical Transplantation · doi:10.1111/ctr.13663 · Cited by 38
Self-citationDiversity of Participants in the 340B Drug Pricing Program for US Hospitals
Nikpay, S., Buntin, M. J. B., & Conti, R. M. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.2015 · Cited by 36
Andújar, A. M., Robles, P., Cibeira, M. T., Montagud‐Marrahí, E., Guillén, E., Xipell, M., Blasco, M., Poch, E., Rosiñol, L., Bladé, J., et al. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01771-3 · Cited by 35
2019 Methodology for Creating Expert Consensus Decision Pathways
Januzzi, J. L., Ahmad, T., Binder, L. G., Hucker, W. J., Kumbhani, D. J., Maddox, T. M., Marine, J. E., & Morris, P. B. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.035 · Cited by 33
Cuscaden, C., Ramsay, S., Prasad, S., Goodwin, B., & Smith, J. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02152-x · Cited by 33
Bortezomib-induced acute interstitial nephritis
Cheungpasitporn, W., Leung, N., Rajkumar, S. V., Cornell, L. D., Sethi, S. M., Angioi, A., & Fervenza, F. C. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv222 · Cited by 32
Management of the elderly patient with AL amyloidosis
Nuvolone, M., Milani, P., Palladini, G. O., & Merlini, G. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.05.004 · Cited by 25
Management of Chronic Diarrhea in Primary Care: The Gastroenterologists’ Advice
Hammer, H. F. (2021) · Digestive Diseases · doi:10.1159/000515219 · Cited by 23
Kurian, S. M., Novais, M., Whisenant, T. C., Gelbart, T., Buxbaum, J. N., Kelly, J. W., Coelho, T., & Salomon, D. R. (2016) · Theranostics · doi:10.7150/thno.14584 · Cited by 22
Cardiac Amyloidosis: Multi-modal Imaging of Disease Activity and Response to Treatment
Patel, R., Fontana, M., & Ruberg, F. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.121.009025 · Cited by 21
Self-citationCardiac transplantation outcomes in patients with amyloid cardiomyopathy
Ohiomoba, R., Youmans, Q. R., Ezema, A., Akanyirige, P., Anderson, A. S., Bryant, A., Jackson, K., Mandieka, E., Pham, D. T., Rich, J. D., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.02.016 · Cited by 20
Carry, B. J., Young, K., Fielden, S., Kelly, M., Sturm, A., Avila, J., Martin, C. L., Kirchner, H., Fornwalt, B. K., & Haggerty, C. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.07.002 · Cited by 19
Chiu, A., Dasari, S., Kurtin, P. J., Theis, J., Vrana, J., Dispenzieri, A., Rech, K., Dao, L., Howard, M., Grogan, M., et al. (2022) · Amyloid: Journal of Protein Folding Disorders · doi:10.1080/13506129.2022.2031963 · Cited by 19
Trachtenberg, B. H., Jiménez, J., Morris, A. A., Kransdorf, E. P., OWENS, A. T., Fishbein, D. P., Jordan, E., Kinnamon, D. D., Mead, J. O., Huggins, G. S., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.03.011 · Cited by 18
Self-citationTerao, T., Tsushima, T., Miura, D., Ikeda, D., Fukumoto, A., Kuzume, A., Tabata, R., Narita, K., Takeuchi, M., & Matsue, K. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2022.2057485 · Cited by 16
Kidney Transplantation in Systemic Amyloidosis
Angel-Korman, A., & Havasi, A. (2020) · Transplantation · doi:10.1097/tp.0000000000003170 · Cited by 15
Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis.
Law, S., Fontana, M., & Gillmore, J. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.04.010 · Cited by 15
Pretransplant Cardiac Evaluation Using Novel Technology
Hemu, M., Zimmerman, A., Kalra, D. K., & Okwuosa, T. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050690 · Cited by 13
Palliative care and symptom management in amyloidosis: A review
Tsukanov, J. M., & Fabbro, E. D. (2016) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2016.09.006 · Cited by 12
Liver and Gastrointestinal Involvement
Rosenzweig, M. A., & Kastritis, E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.11.001 · Cited by 11
Adams, D., Tournev, I., Taylor, M., Coelho, T., Planté‐Bordeneuve, V., Berk, J. L., González‐Duarte, A., Gillmore, J. D., Low, S.-C., Sekijima, Y., et al. (2021) · Neurology · doi:10.1212/wnl.96.15_supplement.1234 · Cited by 8
Alreshq, R. S., Cozzolino, M. J., Lilleness, B., Pipilas, A. R., Mendelson, L. M., Joshi, T., Muralidhar, V., Guardino, E. T., Berk, J. L., Siddiqi, O. K., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.06.064 · Cited by 8
Self-citation2019 Methodology for Heart House Roundtables
Morris, P. B., Kovacs, R. J., Allen, L. A., Binder, L. G., Birtcher, K. K., Covington, A. M., Gluckman, T. J., & Williams, K. A., Sr. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.05.034 · Cited by 5
A pharmacist’s review of the treatment of systemic light chain amyloidosis
Hughes, D., Staron, A., & Sanchorawala, V. (2020) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155220963534 · Cited by 4
Self-citation
Cited by
Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.393 · Cited by 554
Self-citationBozkurt, B., Ahmad, T., Alexander, K., Baker, W. L., Bosak, K., Breathett, K., Carter, S., Drazner, M. H., Dunlay, S. M., Fonarow, G. C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.07.001 · Cited by 427
Cheng, R. K., Kittleson, M. M., Beavers, C. J., Birnie, D. H., Blankstein, R., Bravo, P. E., Gilotra, N. A., Judson, M. A., Patton, K. K., Rose-Bovino, L., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001240 · Cited by 259
Self-citationOikonomou, E. K., Sangha, V., Vasisht Shankar, S., Coppi, A., Krumholz, H. M., Nasir, K., Miller, E. J., Gallegos-Kattan, C., Al-Mallah, M. H., Al-Kindi, S., et al. (2024) · doi:10.1101/2024.08.25.24312556 · Cited by 7
Metadata
- Authors
- Kittleson, M. M., Ruberg, F. L., Ambardekar, A. V., Brannagan, T. H., Cheng, R. K., Clarke, J. O., Dember, L. M., Frantz, J. G., Hershberger, R. E., Maurer, M. S., Nativi-Nicolau, J., Sanchorawala, V., & Sheikh, F. H.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 81
- Issue
- 11
- Pages
- 1076-1126
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W4317761849
- Cited by
- 640
- References
- 175
- FWCI
- 47.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.